A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2011
11/10/2011	CA2797846A1 Methods for the treatment of il-1.beta. related conditions
11/09/2011	EP2385035A1 Preparation method of dihydroindene amide compounds their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2200600B1 Neramexane for use in the treatment of sub-acute tinnitus
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	CN1899339B Medicinal composition for treating acute and chronic conjunctivitis for eye and its preparing method
11/09/2011	CN102238949A Composition and method for treating dry eye syndrome
11/09/2011	CN102233132A Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization
11/09/2011	CN102233129A Long-acting sustained release preparation for preventing or treating retinal damage, and preparation method thereof
11/09/2011	CN102233097A Quality control method for Zengguang capsules
11/09/2011	CN102233070A Traditional Chinese medicine for treating tinnitus
11/09/2011	CN102233027A Traditional Chinese medicine for treating enteritis
11/09/2011	CN102233008A Traditional Chinese medicine for treating otitis media
11/09/2011	CN102232951A Medicament for treating allergic conjunctivitis and preparation method thereof
11/09/2011	CN102232553A Nutrient absorbing composition
11/09/2011	CN101966246B Compound tincture for treating external acoustic meatus fungal infection
11/09/2011	CN101810629B Composition injection of glycerol and fructose and preparation method thereof
11/09/2011	CN101780228B Traditional Chinese medicine composition for treating tinnitus and preparation method thereof
11/09/2011	CN101301417B Powder for treating circumscribed external otitis
11/09/2011	CN101185708B Powder agent medicine for treating acute otitis media suppurative
11/09/2011	CN101032683B Xanthin micro-capsule and the preparing method
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	US8053424 Composition and method of treating hearing loss
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2476430C Sodium channel blockers
11/08/2011	CA2470396C Methods for preserving ophthalmic solutions and preserved ophthalmic solutions
11/08/2011	CA2451552C Topical application of thiazolylamides
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/05/2011	CA2817112A1 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
11/03/2011	WO2011137363A1 Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
11/03/2011	WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011	WO2011137228A2 Composition and method for treating eustachian tube dysfunction
11/03/2011	WO2011137126A1 Formulations of quinones for the treatment of ophthalmic diseases
11/03/2011	WO2011136927A1 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/03/2011	WO2011136161A1 Prophylactic or therapeutic medication for inner ear disorders
11/03/2011	WO2011136159A1 Composition for the treatment of aesthenopia
11/03/2011	WO2011135067A1 Modified binding proteins inhibiting the vegf-a receptor interaction
11/03/2011	US20110269822 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
11/03/2011	US20110269807 Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
11/03/2011	US20110269796 Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines
11/03/2011	US20110269779 Methods and compositions for treatment of ophthalmic conditions
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269719 Pharmaceutical compositions with phosphonium antimicrobial agents
11/03/2011	US20110269715 Abnormal cannabidiols as agents for lowering intraocular pressure
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110268827 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications
11/03/2011	US20110268817 Compounds useful for the prevention or treatment of accomodative asthenopia
11/03/2011	US20110268787 Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
11/03/2011	US20110268783 Partially microcellular, selectively hydrophilic composite construct for ocular drug delivery
11/03/2011	US20110268735 Multimeric constructs
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268723 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268705 Hdac4, hdac5, hdac6, hdac7, and hif1 alpha modulation of retinal cell survival
11/03/2011	US20110268669 Composition and method for treating eustachian tube dysfunction
11/03/2011	US20110268662 Functionalized nanoceria composition for ophthalmic treatment
11/03/2011	CA2791360A1 A pharmaceutical for preventing or treating an inner ear disorder
11/02/2011	EP2383341A1 Compositions and methods for siRNA inhibition of angiogenesis
11/02/2011	EP2382218A1 Delta-5-desaturase inhibitors
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2382013A1 Selective histamine h4 receptor antagonists for the treatment of vestibular disorders.
11/02/2011	EP2381936A1 Pathways to generate hair cells
11/02/2011	CN102228653A Ethanol extract of galangal fruit and medical application thereof
11/02/2011	CN102228639A Medicine for treating vertigo
11/02/2011	CN102228626A Traditional Chinese medicine for treating tinnitus and deafness
11/02/2011	CN102228580A Chinese herbal composition for treating sudden deafness
11/02/2011	CN102228497A Processing method of chrysanthemum
11/02/2011	CN102228445A Freeze-dried powder of ectoine or ectoine derivative for injection
11/02/2011	CN102228428A Large volume injection composition containing vinpocetine and preparation method thereof
11/02/2011	CN101549067B Chinese medicinal composition and uses thereof
11/02/2011	CN101511357B Method for the treatment and prevention of ocular disorders
11/02/2011	CN101160306B Benzimidazole compound
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
10/2011
10/27/2011	WO2011133566A2 Repairing bruch's membrane with hydrogels
10/27/2011	WO2011131765A2 Artificial tear emulsion
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	US20110263721 Aryl di-substituted propenone compounds
10/27/2011	US20110263680 Reduced size self-delivering rnai compounds
10/27/2011	US20110263678 Inhibitors of tgf-r signaling for treatment of cns disorders
10/27/2011	US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011	US20110263658 Renin inhibitors
10/27/2011	US20110263652 Treatment and/or Prevention of Inner Ear Conditions by Modulation of a Metabotropic Glutamate Receptor
10/27/2011	US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011	US20110263645 Compositions and Methods of Treating Retinal Disease
10/27/2011	US20110263638 Therapeutic agent for glaucoma comprising rho kinase inhibitor and ß- blocker
10/27/2011	US20110263611 Kinase Inhibitors
10/27/2011	US20110263600 Method for preventing or treating a disease related to the glucocorticoid receptor
10/27/2011	US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease

1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 531